Name: Wanbury Limited Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 916 across all filing types

Latest filing 2023-06-22 Regulatory Filings

Country IN India

Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing	Released	Lang
Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 07-Jul-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-06-22	English
Board Meeting — Financial Results Regulatory Filings	2023-06-22	English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2023 ,inter alia, to consider and approve Further to our letter dated 22nd May, .... Regulatory Filings	2023-06-22	English
Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 26-Jun-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-06-07	English
Board Meeting — Financial Results Regulatory Filings	2023-06-07	English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2023 ,inter alia, to consider and approve Further to our letter dated 22nd May, .... Regulatory Filings	2023-06-07	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2023 15 filings
	43984111	Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 07-Jul-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-06-22	English
	43983311	Board Meeting — Financial Results Regulatory Filings	2023-06-22	English
	46590950	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2023 ,inter alia, to consider and approve Further to our letter dated 22nd May, .... Regulatory Filings	2023-06-22	English
	43983292	Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 26-Jun-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-06-07	English
	43984663	Board Meeting — Financial Results Regulatory Filings	2023-06-07	English
	46590964	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2023 ,inter alia, to consider and approve Further to our letter dated 22nd May, .... Regulatory Filings	2023-06-07	English
	46590978	With reference to the above captioned subject and in furtherance to our intimation dated 22nd May, 2023 and 25th May, 2023, notice is hereby given that pursuant to Regulation 29 of SEBI .... Regulatory Filings	2023-06-07	English
	46590985	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2023 ,inter alia, to consider and approve Further to our letter dated 22nd May, .... Regulatory Filings	2023-06-07	English
	42938657	Annual Secretarial Compliance Report Regulatory Filings	2023-05-29	English
	46590975	Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Regulations') In line with the provisions of the Companies Act, 2013, we are enclosing .... Regulatory Filings	2023-05-29	English
	43984644	Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 09-Jun-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-05-25	English
	43991922	Board Meeting — Financial Results Regulatory Filings	2023-05-25	English
	46590989	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2023 ,inter alia, to consider and approve Audited Financial Statement & Results .... Regulatory Filings	2023-05-25	English
	43991929	Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly… Regulatory Filings	2023-05-22	English
	43991898	Board Meeting — Financial Results Regulatory Filings	2023-05-22	English

Page 31 of 62

Prev … 29 30 31 32 33 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Wanbury Limited via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60248

TickerWANBURY

ISININE107F01022

Endpoints

most-used routes for this company

GET	/api/companies/60248/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60248	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60248	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Wanbury Limited

$ curl https://api.financialreports.eu/api/filings/?company=60248 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60248},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Wanbury Limited (id: 60248)"

Wanbury Limited — Investor Relations & Filings